Singapore to revolutionise therapeutics for cancer & infectious diseases

Duke-NUS, Xylonix join forces to improve effectiveness of Xylonix cancer drugs

Related Keywords

Singapore ,Ann Marie Chacko ,Christopher Laing ,Singapore Health ,Stem Cell Biology Programme ,Industry Alignment Fund Pre ,Biomedical Sciences ,Assistant Professor ,Professor Christopher Laing ,Industry Alignment Fund Pre Positioning ,Dancer ,Drug ,Disease ,Us ,Xylonix ,